# Effect of Vildagliptin in Type 2 Diabetes Treated With Sulphonylurea and Metformin

> **NCT01099137** · PHASE4 · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 344 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** Vildagliptin
- **DRUG:** Sulphonylurea dose-up

## Key facts

- **NCT ID:** NCT01099137
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-05
- **Target enrollment:** 344 (ACTUAL)
- **Last updated:** 2014-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01099137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01099137, "Effect of Vildagliptin in Type 2 Diabetes Treated With Sulphonylurea and Metformin". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01099137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*